Menu
Recruiting NCT06721234

Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

Observational Behçet

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Behçet. Basic parameters: 19 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations

Primary outcome measures

  • Femoral Vein Wall thickness [Time frame: One week]

Eligibility criteria

Inclusion criteria

  • Patients fulfill the International Criteria for Behcet's Disease (ICBD)
  • Age above 18 years old
  • Patients cooperative and can answer questions
  • Patients who are able and willing to give informed consent

Exclusion criteria

  • Other rheumatological and vascular diseases
  • Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
  • Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
  • Patients who are using aspirin and other platelet active drygs during the previous 6 months
  • patients who are not able and willing to give written consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Egypt · 1 center
  • Sohag university — Sohag

Identifiers

NCT: NCT06721234 · Soh-Med--24-11-03MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗